1. Direct-acting antivirals assessed by UK's MHRA

   News item 04 February 2017 Pages: 1 - 1

2. Emerging safety issues for hepatitis C antivirals

   News item 04 February 2017 Pages: 2 - 2

3. hCG not approved for weight loss, reminds Health Canada

   News item 04 February 2017 Pages: 3 - 3

4. Known rare ADRs of FQs "may be persistent and/or disabling"

   News item 04 February 2017 Pages: 4 - 4

5. Potential need for continued NAC for paracetamol overdose

   News item 04 February 2017 Pages: 5 - 5

6. US ISMP assesses 87 drugs with insomnia signals

   News item 04 February 2017 Pages: 6 - 6

7. Atypical antipsychotics in adults with dementia: benefits vs harms

   Clinical study 04 February 2017 Pages: 7 - 7

8. Cardiac mortality in child cancer survivors

   Clinical study 04 February 2017 Pages: 8 - 8

9. Drug-related sleep disturbance

   Clinical study 04 February 2017 Pages: 9 - 9

10. Omalizumab: arterial thrombolic event rate not increased

    Clinical study 04 February 2017 Pages: 10 - 10

11. Patient-reported cancer treatment toxicities

    Clinical study 04 February 2017 Pages: 11 - 11

12. Splenic enlargement with trastuzumab emtansine

    Clinical study 04 February 2017 Pages: 12 - 12

13. Adalimumab

    Case report 04 February 2017 Pages: 13 - 13

14. Adalimumab/etanercept

    Case report 04 February 2017 Pages: 14 - 14

15. Alendronic acid/zoledronic acid

    Case report 04 February 2017 Pages: 15 - 15

16. Amfetamine/Benzodiazepines/Methadone

    Case report 04 February 2017 Pages: 16 - 16

17. Amikacin/ceftazidime/meropenem

    Case report 04 February 2017 Pages: 17 - 17

18. Amiodarone

    Case report 04 February 2017 Pages: 18 - 18

19. Amiodarone

    Case report 04 February 2017 Pages: 19 - 19

20. Amiodarone/antiarrhythmics

    Case report 04 February 2017 Pages: 20 - 20

21. Amiodarone/phenytoin

    Case report 04 February 2017 Pages: 21 - 21

22. Amoxicillin/clavulanic-acid/bisoprolol/losartan

    Case report 04 February 2017 Pages: 22 - 22

23. Antineoplastics

    Case report 04 February 2017 Pages: 23 - 23

24. Antineoplastics

    Case report 04 February 2017 Pages: 24 - 24

25. Antineoplastics

    Case report 04 February 2017 Pages: 25 - 25

26. Antineoplastics

    Case report 04 February 2017 Pages: 26 - 26

27. Antineoplastics

    Case report 04 February 2017 Pages: 27 - 27

28. Antituberculars

    Case report 04 February 2017 Pages: 28 - 28

29. Aripiprazole

    Case report 04 February 2017 Pages: 29 - 29

30. Aripiprazole/quetiapine/risperidone

    Case report 04 February 2017 Pages: 30 - 30

31. Asenapine

    Case report 04 February 2017 Pages: 31 - 31

32. Atenolol

    Case report 04 February 2017 Pages: 32 - 32

33. Azathioprine/infliximab/prednisone

    Case report 04 February 2017 Pages: 33 - 33

34. Baclofen

    Case report 04 February 2017 Pages: 34 - 34

35. Belatacept

    Case report 04 February 2017 Pages: 35 - 35

36. Bendamustine

    Case report 04 February 2017 Pages: 36 - 36

37. Benzocaine

    Case report 04 February 2017 Pages: 37 - 37

38. Bevacizumab

    Case report 04 February 2017 Pages: 38 - 38

39. Bevacizumab

    Case report 04 February 2017 Pages: 39 - 39

40. Bevacizumab/irinotecan/temozolomide

    Case report 04 February 2017 Pages: 40 - 40

41. Brimonidine

    Case report 04 February 2017 Pages: 42 - 42

42. Bupivacaine/Lidocaine interaction

    Case report 04 February 2017 Pages: 43 - 43

43. Buprenorphine/methadone

    Case report 04 February 2017 Pages: 44 - 44

44. Buprenorphine/naloxone

    Case report 04 February 2017 Pages: 45 - 45

45. Calcium/levothyroxine sodium interaction

    Case report 04 February 2017 Pages: 46 - 46

46. Capecitabine

    Case report 04 February 2017 Pages: 47 - 47

47. Capecitabine/cisplatin/trastuzumab

    Case report 04 February 2017 Pages: 48 - 48

48. Carbamazepine

    Case report 04 February 2017 Pages: 49 - 49

49. Carboplatin

    Case report 04 February 2017 Pages: 50 - 50

50. Carvedilol/diltiazem

    Case report 04 February 2017 Pages: 51 - 51